-
Cambrex Expands Analytical Capabilities at High Point
contractpharma
December 13, 2018
Cambrex Corp., a manufacturer of small molecule active pharmaceutical ingredients (APIs), and finished dosage forms, is investing $1 million at its High Point, NC site to add 1,300 sq.-ft.
-
Boehringer follows Sanofi with job cuts in France
pharmaphorum
December 12, 2018
Boehringer Ingelheim has confirmed it plans to axe more than 10% of its workforce in France, or more than 300 jobs, adding to several hundred losses at Sanofi last week.
-
Fishawack acquires marketing consultancy Blue Latitude Health
pharmaphorum
December 11, 2018
Independent medical communications and marketing group Fishawack has acquired Blue Latitude Health.he move comes shortly after the UK-based group restructured ....
-
Delaware Supreme Court allows Fresenius to abandon Akorn acquisition
pharmaceutical-technology
December 11, 2018
The Delaware Supreme Court in the US has ruled that German health care company Fresenius could legally back out of its acquisition of US-based Akorn....
-
After delayed IPO, Mereo gets US listing via OncoMed merger
pharmaphorum
December 10, 2018
UK biotech Mereo BioPharma is merging with Californian biotech OncoMed in an all-stock deal that swells its pipeline and gives it a potential licensing deal with Celgene......
-
M&As : GlaxoSmithKline, Takeda, Procter & Gamble
pharmaceutical-technology
December 10, 2018
GlaxoSmithKline?(GSK) has agreed to acquire US-based cancer treatment developer Tesaro for $5.1bn.GSK will acquire all issued and outstanding.....
-
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
worldpharmanews
December 07, 2018
The proposed transaction will significantly strengthen GSK's pharmaceutical business, accelerating the build of GSK's pipeline and commercial capability in oncology.
-
Takeda receives shareholders’ approval to acquire Shire
pharmaceutical-technology
December 06, 2018
Takeda Pharmaceutical has secured shareholder approval for the issuance of its shares necessary to implement the proposed $62bn acquisition of Shire....
-
GSK enters PARP space with TESARO acquisition
pharmaphorum
December 05, 2018
GSK has announced that it will acquire US-based?oncology?specialist TESARO for $5.1 billion, gaining access to its PARP inhibitor Zejula (niraparib).....
-
P&G completes Merck’s Consumer Health unit acquisition for $3.8bn
pharmaceutical-technology
December 04, 2018
Procter & Gamble (P&G) has completed its acquisition of Merck’s Consumer Health business in a €3.4bn ($3.8bn) deal.The acquisition was?announced?in April......
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
